FFCP PHASE1:Mm9::chr17:34443608..34443617,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=48|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:34443608..34443617,+|id=chr17:34443608..34443617,+|ontology_enrichment_celltype=CL:0000553!1.43e-15!6;CL:0000556!1.43e-15!6;CL:0000945!1.83e-11!1;CL:0000236!1.83e-11!1;CL:0000826!1.83e-11!1;CL:0000050!1.33e-10!9;CL:0000414!8.72e-09!11;CL:0000049!1.23e-08!19;CL:0000988!7.36e-08!32;CL:0002032!7.36e-08!32;CL:0000037!7.36e-08!32;CL:0000566!7.36e-08!32;CL:0000837!7.36e-08!32;CL:0000839!1.60e-07!13;CL:0000063!4.08e-07!66;CL:0002031!9.38e-07!25|ontology_enrichment_celltype_v019_2=CL:0000553,4.33e-33,6;CL:0000556,4.33e-33,6;CL:0000945,3.06e-23,1;CL:0000236,3.06e-23,1;CL:0000826,3.06e-23,1;CL:0000050,1.96e-22,9;CL:0000839,7.54e-16,13;CL:0002031,9.61e-15,25;CL:0000763,4.65e-13,16;CL:0000988,1.03e-11,32;CL:0002032,1.03e-11,32;CL:0000037,1.03e-11,32;CL:0000837,1.03e-11,32;CL:0000049,3.83e-11,19;CL:0002320,2.15e-08,46;CL:0000134,2.15e-08,46;CL:0000219,2.91e-07,54|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001242!2.53e-07!13;UBERON:0000060!2.53e-07!13;UBERON:0001262!2.53e-07!13;UBERON:0004786!2.53e-07!13|ontology_enrichment_uberon_v019_2=UBERON:0002371,4.65e-13,16;UBERON:0001474,9.57e-10,22;UBERON:0004765,9.57e-10,22;UBERON:0001434,9.57e-10,22;UBERON:0002384,2.15e-08,46;UBERON:0002204,5.85e-07,32|phase1_expression=0,0.348975407639361,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.73504190947031,1.7824876368746,1.69755860719212,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0.288851619751275,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.02678254538567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:34443608..34443617,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=48 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:34443608..34443617,+ | |||
|description=CAGE_peak_at_chr17:34443608..34443617,+ | |||
|id=chr17:34443608..34443617,+ | |||
|ontology_enrichment_celltype=CL:0000553!1.43e-15!6;CL:0000556!1.43e-15!6;CL:0000945!1.83e-11!1;CL:0000236!1.83e-11!1;CL:0000826!1.83e-11!1;CL:0000050!1.33e-10!9;CL:0000414!8.72e-09!11;CL:0000049!1.23e-08!19;CL:0000988!7.36e-08!32;CL:0002032!7.36e-08!32;CL:0000037!7.36e-08!32;CL:0000566!7.36e-08!32;CL:0000837!7.36e-08!32;CL:0000839!1.60e-07!13;CL:0000063!4.08e-07!66;CL:0002031!9.38e-07!25 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,4.33e-33,6;CL:0000556,4.33e-33,6;CL:0000945,3.06e-23,1;CL:0000236,3.06e-23,1;CL:0000826,3.06e-23,1;CL:0000050,1.96e-22,9;CL:0000839,7.54e-16,13;CL:0002031,9.61e-15,25;CL:0000763,4.65e-13,16;CL:0000988,1.03e-11,32;CL:0002032,1.03e-11,32;CL:0000037,1.03e-11,32;CL:0000837,1.03e-11,32;CL:0000049,3.83e-11,19;CL:0002320,2.15e-08,46;CL:0000134,2.15e-08,46;CL:0000219,2.91e-07,54 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001242!2.53e-07!13;UBERON:0000060!2.53e-07!13;UBERON:0001262!2.53e-07!13;UBERON:0004786!2.53e-07!13 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002371,4.65e-13,16;UBERON:0001474,9.57e-10,22;UBERON:0004765,9.57e-10,22;UBERON:0001434,9.57e-10,22;UBERON:0002384,2.15e-08,46;UBERON:0002204,5.85e-07,32 | |||
|phase1_expression=0,0.348975407639361,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.73504190947031,1.7824876368746,1.69755860719212,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0.288851619751275,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.02678254538567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:34443608..34443617,+ | |||
}} |
Latest revision as of 17:16, 4 August 2015
Short description: | p@chr17:34443608..34443617, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:34443608..34443617, + |
Coexpression cluster: | MCL_coexpression_mm9:48 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 4.33e-33 | 6 |
megakaryocyte | 4.33e-33 | 6 |
lymphocyte of B lineage | 3.06e-23 | 1 |
B cell | 3.06e-23 | 1 |
pro-B cell | 3.06e-23 | 1 |
megakaryocyte-erythroid progenitor cell | 1.96e-22 | 9 |
myeloid lineage restricted progenitor cell | 7.54e-16 | 13 |
hematopoietic lineage restricted progenitor cell | 9.61e-15 | 25 |
myeloid cell | 4.65e-13 | 16 |
hematopoietic cell | 1.03e-11 | 32 |
hematopoietic oligopotent progenitor cell | 1.03e-11 | 32 |
hematopoietic stem cell | 1.03e-11 | 32 |
hematopoietic multipotent progenitor cell | 1.03e-11 | 32 |
common myeloid progenitor | 3.83e-11 | 19 |
connective tissue cell | 2.15e-08 | 46 |
mesenchymal cell | 2.15e-08 | 46 |
motile cell | 2.91e-07 | 54 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 4.65e-13 | 16 |
bone element | 9.57e-10 | 22 |
skeletal element | 9.57e-10 | 22 |
skeletal system | 9.57e-10 | 22 |
connective tissue | 2.15e-08 | 46 |
musculoskeletal system | 5.85e-07 | 32 |